Suchergebnisse - "Gupta, Neeraj"

PubPharm (3)

1

A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis

enthalten in: Blood | 2017

von Sanchorawala, V. | Palladini, G. | Kukreti, V. | +12

ErratumIn: Blood. 2020 Mar 26;135(13):1071. - PMID 32219354

2

Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma

enthalten in: Blood | 2014

von Kumar, S. | Bensinger, W. | Zimmerman, T. | +9

CommentIn: Blood. 2014 Aug 14;124(7):986-7. - PMID 25124778

3

Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients

enthalten in: Blood | 2014

von Richardson, P. | Baz, R. | Wang, M. | +11

CommentIn: Blood. 2014 Aug 14;124(7):986-7. - PMID 25124778

1
[1]